Addressing the Barriers to Pediatric Drug Development: Workshop Summary (2008)

Chapter: 2 Regulatory Framework

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 1 Introduction
Page 10 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 10
Page 11 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 11
Page 12 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 12
Page 13 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 13
Page 14 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 14
Page 15 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 15
Page 16 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 16
Page 17 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 17
Page 18 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 18
Page 19 Cite
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Save
Cancel
Page 19
Next Chapter: 3 Current Challenges in Developing and Prescribing Drugs for Children
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.